Navigation Links
Bill Dunham and Mark Trimmer, DunhamTrimmer LLC and 2B Monthly, Will Be Attending the Annual Biocontrol Industry Meeting (ABIM) in Basel, Switzerland on October 21-23
Date:10/21/2013

(PRWEB) October 21, 2013

Annual Biocontrol Industry Meeting, Basel, Switzerland, organized by the International Biocontrol Manufacturers Association (IBMA) and the Research Institute of Organic Agriculture (FiBL). The prime international meeting on biocontrol, the 8th annual gathering will be held in a new location in Basel, having outgrown the previous location in Lucerne.

About Bill Dunham: Bill has more than 35 years international agribusiness experience in the seed, biotechnology, crop protection, and biopesticide businesses. Bill has successfully developed and launched crop protection products in more than 50 countries while leading international marketing projects at BASF, American Cyanamid, DeKalb Seeds, ICI, and Stauffer Chemical Company. In 2003 Bill joined AgraQuest VP of International Business and was responsible for designing and implementing international business plans which led to thriving growth for their biopesticide products in international markets. In 2007, Bill launched his own consulting company, International Bio Consultants LLC, which is focused on providing world class global project management for its clients in the biopesticide market. Subsequently in 2011 Bill and Dr. Mark Trimmer co-founded DunhamTrimmer LLC, the premier market research company for the biopesticide and biostimulant industries. In April of 2013 DunhamTrimmer and New Ag International jointly launched the 2BMonthly Newsletter providing the latest news on the biopesticide/biostimulant industries. With three businesses focused on biopesticides and biostimulants, Bill is a renowned expert on those industries. He has contributed to numerous articles and conferences on those industries.

About Mark Trimmer: Mark Trimmer has more than 25 years of experience in research, product development, registration, technical service, and technology licensing in the crop protection industry. Mark led international product development at American Cyanamid and successfully delivered numerous new product registrations. At BASF, he led new technology acquisition for the agriculture division and successfully negotiated development agreements on several new products. Most recently, Mark led R&D efforts at a biological startup company, NutraPark, and successfully developed novel biological PGR’s for enhancing fresh market fruits and vegetables. In 2006, Mark established his own company providing new technology assessment, R&D strategy, regulatory, and product development services to clients in the global agricultural chemical and biological markets. In April of 2013 DunhamTrimmer and New Ag International jointly launched the 2BMonthly Newsletter providing the latest news on the biopesticide/biostimulant industries.

Read the full story at http://www.prweb.com/releases/2013/10/prweb11250231.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. DunhamTrimmer's, Bill Dunham and Mark Trimmer Are Invited Speakers at the Biopesticide Conference Organized by Informa in Raleigh, NC on August 7-8, 2013
2. Bill Dunham, Managing Partner, DunhamTrimmer LLC and Editor, 2B Monthly Will Be a Guest Speaker at the 2013 BCPC Congress
3. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
4. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
5. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
6. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
7. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
8. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
9. 15-Minute Data From Phase 3 Study of Avanafil Featured as a Late Breaking Abstract at SMSNA Annual Meeting
10. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
11. Masimo to Present at 23rd Annual Piper Jaffray Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the ... today announced its financial results for the fourth quarter and ... Financial Highlights Total sales in the ... or increased by 13.6% in USD terms to $77.6 million ... Gross profit increased by 13.3% to $46.8 million ...
(Date:2/23/2017)... and NEW YORK , ... Lumeon , a leading digital health company, ... a provider of telemedicine and remote patient monitoring, ... for telemedicine reimbursements.  DN Telehealth ... patients, in real-time, extending consultations beyond a physical ...
(Date:2/23/2017)... TORONTO , Feb. 23, 2017 /PRNewswire/ - The ... Institute for Cancer Research (OICR) are pleased to report ... Series A financing, with Johnson & Johnson Innovation – ... investors include venture groups HealthCap, TPG Biotechnology Partners, and ... ...
(Date:2/23/2017)... SEATTLE , Feb. 23, 2017  Seattle,s upscale Capitol ... like a strange place for a head lice treatment salon ... nestled between a Tuscan restaurant and a French bistro on ... it,s perfect. "We aren,t just any old lice clinic, we ... to feel comfortable, and release some of the stigma associated ...
Breaking Biology Technology:
(Date:2/8/2017)... 2017  Aware, Inc. (NASDAQ: AWRE ), a ... results for its quarter and year ended December 31, 2016. ... was $3.9 million compared to $6.9 million in the same ... 2016 was $0.6 million compared to $2.6 million in the ... of 2016 was $0.5 million, or $0.02 per diluted share, ...
(Date:2/7/2017)... , Feb. 7, 2017 Zimmer Biomet ... in musculoskeletal healthcare, will present at the LEERINK Partners ... York Palace Hotel on Wednesday, February 15, 2017 at ... webcast of the presentation can be accessed at ... following the conference via Zimmer Biomet,s Investor Relations website ...
(Date:2/2/2017)... 2017   TapImmune, Inc. (NASDAQ: ... in the development of innovative peptide and gene-based ... and metastatic disease, announced today it has successfully ... a second clinical lot of TPIV 200, the ... The manufactured vaccine product will be used to ...
Breaking Biology News(10 mins):